Approaches to the management of surgical patients with antibiotic-associated mild diarrhea

The paper  highlights  the issues  of antibiotic-associated diarrhea  (AAD) of mild severity in the treatment of surgical patients, its epidemiology, etiology, features  of the clinical picture and approaches to therapy. The mild course of AAD includes diarrhea without  signs  of intoxication,  leukocytosis  and  fever. Stool  disorder  in patients receiving  antibiotics  who are  in a surgical hospital  is an urgent  medical  problem, since  this pathology  prolongs  the  time  of hospitalization, increases  economic  costs, reduces  the quality of life and can even be the cause of the patient’s death. According to various authors, AAD develops  in 40% of people  receiving antibacterial therapy. A clinical example  of the management of a patient  with AAD and injury of the musculoskeletal system is considered in detail.The abolition of antibiotics  is not a method  of solving this problem, since the severity of the patient’s injuries requires  further surgical treatment and prevention of purulent-septic complications. The key point in the  treatment of mild AAD will be the  appointment of probiotic  drugs, which have  an effect  on the  pathogenetic  links of AAD. Probiotics  are  microorganisms that  have  been  known  since  ancient  times  and  are  purposefully  used  for health improvement and longevity. One of the first probiotic drugs used before the era of the discovery of antibiotics  can be considered  Mechnikov curdled  milk with  unique  medicinal  properties.  Prescribing  probiotic  therapy  from the  first day of taking antibiotics, without  waiting for the results  of laboratory examination, will significantly reduce  the prevalence of clinical manifestations of both clostridial  diarrhea  and idiopathic AAD.

1. Shapovalova MM, Budnevsky AV, Kravchenko AYa, Drobysheva ES, Ovsyannikov ES. Antibiotic-Associated Diarrhea: Pathogenesis, Actual Aspects of Prevention and Treatment. The Russian Archives of Internal Medicine. 2018;8(6):424–429. https://doi.org/10.20514/2226-6704-2018-8-6-424-429.

2. Kosyura SD, Ilchenko LYu, Pozharitskaya EI, Merzlikina NN. Antibiotic-associated diarrhea. Lechebnoe Delo. 2015;(1):131–134. (In Russ.) Available at: https://www.atmosphere-ph.ru/modules/Magazines/articles/delo/ld_1_2015_131.pdf.

3. Shlyapnikov SA, Naser NR, Batyrshin IM, Borodina MA, Sklizkov DS, Ostroumova YuS, Ryazanova EP. The Antibiotic-associated colitis is a new problem in surgery. Bulletin of Pirogov National Medical & Surgical Center. 2020;15(2):138–143. (In Russ.) https://doi.org/10.25881/BPNMSC.2020.62.96.024.

4. Al Sharaby A, Abugoukh TM, Ahmed W, Ahmed S, Elshaikh AO. Do Probiotics Prevent Clostridium difficile-Associated Diarrhea? Cureus. 2022;14(8):e27624. https://doi.org/10.7759/cureus.27624.

5. Kryukov EV, Popova TN, Parinov OV, Meshkov VV. Antibiotic-associated states in the clinical practice of a gatroenterologist in a multifunctional medical centre. Infectious Diseases: News, Opinions, Training. 2017;(6):79–84. (In Russ.) https://doi.org/10.24411/2305-3496-2017-00008.

6. Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095. https://doi.org/10.1002/14651858.CD006095.pub4.

7. Fominykh YuA, Pakhomova IG. Antibiotic-associated conditions in medical practice: relevance of the problem, solutions. RMJ. 2012;(15):754–757. (In Russ.) Available at: https://www.rmj.ru/articles/gastroenterologiya/Antibiotikassociirovannye_sostoyaniya_v_medicinskoy_praktike_aktualynosty_problemy_puti_resheniya/.

8. Osipenko MF, Bikbulatova EA. Complications of antibiotic therapy and their correction. Spravochnik Poliklinicheskogo Vracha. 2012;(6):29–33. (In Russ.) Available at: https://omnidoctor.ru/upload/iblock/ce9/ce9f5b49c7f3e3d9d3294e1e810dba62.pdf.

9. Zakharenko SM. Toxin-producing Klebsiella oxytoca as a cause of antibiotic-associated colitis. Almanac of Clinical Medicine. 2018;46(5):497–503. (In Russ.) https://doi.org/10.18786/2072-0505-2018-46-5-497-503.

10. La Fata G, Weber P, Mohajeri MH. Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob Proteins. 2018;10(1):11–21. https://doi.org/10.1007/s12602-017-9322-6.

11. Uspenskiy YuP, Baryshnikova NV. Antibiotic-associated diarrhea in hospital: frequency and prophylaxis. Medical Alphabet. 2021;(20):35–37. (In Russ.) https://doi.org/10.33667/2078-5631-2021-20-35-37.

12. Plotnikova EYu, Zakharova IuV. Place of probiotics in the prevention and treatment of antibiotic-associated diarrhea. Terapevticheskii Arkhiv. 2015;87(5):127–131. (In Russ.) https://doi.org/10.17116/terarkh2015875127-131.

13. Evdokimova AG, Zhukolenko LV, Ivanova TB, Stryuk RI. Correction of intestinal microflora synbiotic Maxilac. Experimental and Clinical Gastroenterology. 2019;(6):62–69. (In Russ.) Available at: https://www.nogr.org/jour/article/view/906.

14. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med. 2016;9:27–37. https://doi.org/10.2147/IJGM.S98280.

15. Alberda C, Marcushamer S, Hewer T, Journault N, Kutsogiannis D. Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile. Nutrients. 2018;10(5):539. https://doi.org/10.3390/nu10050539.

16. Zhu LB, Zhang YC, Huang HH, Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr. 2021;10(5):84–92. https://doi.org/10.5409/wjcp.v10.i5.84.

17. Rodriguez H, Miller JE. Do prophylactic probiotics prevent the incidence of Clostridium difficile colitis infection in hospitalized patients? J Okla State Med Assoc. 2019;112(1):18–19. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677267/.

18. Zavisic G, Petricevic S, Radulovic Z, Begovic J, Golic N, Topisirovic L, Strahinic I. Probiotic features of two oral Lactobacillus isolates. Braz J Microbiol. 2012;43(1):418–428. https://doi.org/10.1590/S1517-838220120001000050.

19. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130(Suppl. 2):396S–402S. https://doi.org/10.1093/jn/130.2.396S.

20. Zhang L, Zeng X, Guo D, Zou Y, Gan H, Huang X. Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (>65 years): a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):562. https://doi.org/10.1186/s12877-022-03257-3.

21. Kopacz K, Phadtare S. Probiotics for the Prevention of Antibiotic-Associated Diarrhea. Healthcare (Basel). 2022;10(8):1450. https://doi.org/10.3390/healthcare10081450.

22. Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(Suppl. 2):S108–121. https://doi.org/10.1093/cid/civ177.

23. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(Suppl. 2):444S–450S. https://doi.org/10.1093/ajcn/73.2.444s.

24. Yun B, Oh S, Griffiths MW. Lactobacillus acidophilus modulates the virulence of Clostridium difficile. J Dairy Sci. 2014;97(8):4745–4758. https://doi.org/10.3168/jds.2014-7921.

25. Zhang W, Zhu B, Xu J, Liu Y, Qiu E, Li Z, Li Z, He Y, Zhou H, Bai Y, Zhi F. Bacteroides fragilis Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses. Front Immunol. 2018;9:1040. https://doi.org/10.3389/fimmu.2018.01040.